Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

Non-small cell lung cancer (NSCLC) develops in lung tissues, but when it's metastatic, it has spread to distant areas of the ...

Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck & Bristol-Myers reshape global treatment pathways. Anurag Tiwari Orion Market Research Pvt Ltd +91 91798 28694 email us here ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease had worsened after an initial round of chemo, according to interim ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer ...

IMDELLTRA ® (tarlatamab-dlle) is indicated for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

Objective: The aim of this study is to develop and validate a predictive model for predicting survival in individual advanced non-small cell lung cancer patients by integrating basic patient ...

Extensive-stage small cell lung cancer: Cancer has spread throughout the lung to the other lung or other parts of the body. Limited-stage small cell lung cancer: Cancer that is on one side of the ...

Learn about small-cell lung cancer, including its symptoms, causes, diagnosis, and treatment, and where to find support.

Learn why small cell lung cancer is difficult to treat and why the outlook is less favorable.

Keywords: circulating-tumor DNA, ctDNA, gene fusion, non-small cell lung cancer, comprehensive genomic profiling Citation: Kim Y-g, Lee B, Ha C, Lee C, Jung HA, Sun J-M, Lee S-H, Ahn M-J, Choi Y-L, ...

Although advancements in treatments for small cell lung cancer (SCLC) are scarce for this aggressive cancer type, recent regulatory developments and trial results indicate that we are on the precipice ...